Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
NCT01442194
·
clinicaltrials.gov ↗
COMPLETED
Status
3076
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
other disease-modifying therapy
DRUG:
Fingolimod
Sponsor
Novartis Pharmaceuticals